Literature DB >> 17024504

A new category--healthcare-associated pneumonia: a good idea, but problems with its execution.

S Fujitani, V L Yu.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17024504     DOI： 10.1007/s10096-006-0197-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  24 in total

1.  New directions for future studies of community-acquired pneumonia: optimizing impact on patient care.

Authors:  E N Vergis; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-12       Impact factor: 3.267

Review 2.  Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia.

Authors:  Victor L Yu; Nina Singh
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

3.  Multicenter study of hospital-acquired pneumonia in non-ICU patients.

Authors:  Nieves Sopena; Miquel Sabrià
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

4.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

Review 5.  The epidemiology and control of Acinetobacter baumannii in health care facilities.

Authors:  Pierre Edouard Fournier; Hervé Richet
Journal:  Clin Infect Dis       Date:  2006-01-26       Impact factor: 9.079

6.  Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

Authors:  J G Bartlett; R F Breiman; L A Mandell; T M File
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

7.  Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

Authors:  S V Yakovlev; L S Stratchounski; G L Woods; B Adeyi; K A McCarroll; J A Ginanni; I R Friedland; C A Wood; M J DiNubile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

8.  Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture.

Authors:  C H A'Court; C S Garrard; D Crook; I Bowler; C Conlon; T Peto; E Anderson
Journal:  Q J Med       Date:  1993-10

Review 9.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

10.  Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

Authors:  J Rello; A Torres; M Ricart; J Valles; J Gonzalez; A Artigas; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405
View more
  4 in total

1.  Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.

Authors:  Wesley H Self; Richard G Wunderink; Derek J Williams; Tyler W Barrett; Adrienne H Baughman; Carlos G Grijalva
Journal:  Acad Emerg Med       Date:  2015-05-20       Impact factor: 3.451

Review 2.  Healthcare-associated Pneumonia and Aspiration Pneumonia.

Authors:  Kosaku Komiya; Hiroshi Ishii; Jun-Ichi Kadota
Journal:  Aging Dis       Date:  2014-02-08       Impact factor: 6.745

3.  Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.

Authors:  Wesley H Self; Richard G Wunderink; Derek J Williams; Yuwei Zhu; Evan J Anderson; Robert A Balk; Sherene S Fakhran; James D Chappell; Geoffrey Casimir; D Mark Courtney; Christopher Trabue; Grant W Waterer; Anna Bramley; Shelley Magill; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

4.  Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department.

Authors:  Scott T Micek; Adam Lang; Brian M Fuller; Nicholas B Hampton; Marin H Kollef
Journal:  BMC Infect Dis       Date:  2014-02-05       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.